Gilead Sciences, Inc.
Therapeutic compounds
Last updated:
Abstract:
The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb): ##STR00001## ##STR00002## which are useful in the treatment of a Retroviridae viral infection including an infection caused by the HIV virus.
Status:
Grant
Type:
Utility
Filling date:
25 Jun 2018
Issue date:
19 May 2020